Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think a BO will happen anytime between now and mid 2019.
JT - "I didn't get much sleep last night"
No kidding! lol
JT is covering RI. How the study exceeded expectations where every other study failed.
In sum. No new info. But JT is doing good job in going over talking points differentiating and promoting V.
Yes, the call has started. JT is speaking.
I dialed in at 7:30am.
Go buy a bottle of V now while supply last. lol
Conference call at 8am. Always better to call in. No interruptions.
877-407-8033
Make it $12
Raf,
Same here. I know I was too much sometimes.
Congrats!
Congrats longs! Our day has finally arrived and I love it!!!
Amen
Just can't decide in the right word. lol
Sorry, you missed the opportunity because you are such a ......
Big gap up tomorrow morning.
Kiwi bought $6 call options. If RI hits big time he'll make money.
Looks like Amarin is moving full speed ahead and not wasting time with selecting new reps for RI expansion.
"how long between interview with the manager did you get a call back for the Skype simulation?"
"Had call with recruiter. About a week later, a call with hiring manager. Then a few days later had f2f with manager, then two days later had a call with regional manager, then a day later had simulation. Give or take took about 2 weeks from start to finish."
http://www.cafepharma.com/boards/threads/expansion.626462/page-4
The fact that Amarin signed partnerships for developing/selling V in China, OAE, Lebanon, Canada and scheduled to terminate partnership with KOWA in the US immediately after RI results, but no partnerships in Europe indicates to me that either GSK or AZN is lined up to scoop AMRN shortly after successful RI. Perhaps the next three months will be exciting starting this coming Monday.
GLTA!
I'm ok with 35%±20
No PR as of 4:05pm. Good!
For the 10th time. Mineral oil is inert. The most likely reason why LDL moved higher in Anchor plasibo arm was short wash out period.
Ziploc, Agreed. That's why I accumulated a sizable position here in the past 6 months.
I expect a PR on Monday morning that will start a new chapter in Amarin history.
During the conference call on 8/27 JT stated "all major steps for DB lock will be completed by August 31st".
How could that happen?
The chart looks awesome from $5 to $25 in 12 months and now this!?
This contradicts with everything FFS taught us. lol
""Official" offers won't go out til after reduce it results are in. Only contingent offers are being communicated vocally at this point. And to that point, I have received a contingent offer. Hope to be joining the team in a few weeks."
http://www.cafepharma.com/boards/threads/offers.628081/
PR tomorrow morning will make my weekend.
Positive or negative I'll probably be drunk in either case. lol
Ha ha there you go! Buy 2029 TEVA calls.
The problem is you are trying to nail something what's completely outside of your control. Some "top science" posters on this board have been all other the place with their predictions. That should be telling.
Want to play safe? Pay a little extra for Jan 19 options that will buy you more time in case things take longer.
Facebook is a waste of time. So No.
Anyone who was buying call options that expire in September should have known that was a big gamble as the company clearly stated "by the end of September". IMO smart investors who wanted to play RI results and subsequent run up in share price purchased Jan 19 call options.
Can't wait for a PR and finally move on to exciting topics: Presentations, Sales, New Label, BO.
Ppl are going nuts here counting days and debugging "false" statements.
Eicosapantaenoic acid treatment based on the EPA/AA ratio in patients with coronary artery disease: follow-up data from the Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD) study.
https://www.nature.com/articles/s41440-018-0102-9?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+hr%2Frss%2Fcurrent+%28Hypertension+Research+-+Issue%29
If a patient doesn't show up for appointment the doc can't bill insurance and make money.
I'm so freaking ready for a "paradigm shift"!
You are kinda late with your game plan. Don't you think so?
JZ has done a lot worse things to Amarin shareholders yet his balls are still on the BOD.
JT should have stated "in the very end of September" instead of "by the end of September".
Canadian cannabis pharma company Tilray symbol TLRY trades at $16bil valuation. How much Amarin will worth with successful RI results?
This has nothing to do with Amarin.
If RI is positive, FDA will cooperate but it won't go above and beyond.
New article that touches Amarin vs. ITC case and DS involvement.
https://www.naturalproductsinsider.com/litigation/court-it-s-good-have-friends
Go away already!
Fu.king Clay is like a plague that just won't go away.
No doubt Amarin will dilute after successful results. The question is how much and at what price.